Skip to main content
Skip to main content
EOFBF logo

Ecofibre Limited (EOFBF) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

DELISTED

What happened to Ecofibre Limited (EOFBF) stock?

Ecofibre Limited (EOFBF) no longer trades on public markets. The figures below are historical and are not a current quote.

Vol: 14.6K| 52-wk range: $0.001 – $0.07

Beta 2.28: the stock has moved about 128% more than the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Ecofibre Limited (EOFBF). Ecofibre Limited cultivates, manufactures, and sells hemp-based products across health, food, and textile sectors in the United States and Australia. The company faces challenges with profitability and operates in a competitive and evolving regulatory landscape. Sector: Healthcare.

Last analyzed: Mar 18, 2026
Ecofibre Limited cultivates, manufactures, and sells hemp-based products across health, food, and textile sectors in the United States and Australia. The company faces challenges with profitability and operates in a competitive and evolving regulatory landscape.

Analyst Coverage for EOFBF: EOFBF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates EOFBF against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the EOFBF film Every key number, told as a short cinematic story — just press play. ~2 min

Dated analysis: the newest financial statements on file are 27 months old (Jun 1, 2024), so the figures and score below describe that period, not today.

Council Score · Weighted Average of 3 Disciplines
Bearish Lean 31/100 · D

EOFBF: 2/2 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated)Ray Dalio
Favorable read
Englander-style lens (simulated)Izzy Englander
Unfavorable read
Klarman-style lens (simulated)Seth Klarman
Unfavorable read
Moon AI lens (model)
Unfavorable read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Negative
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

Ecofibre Limited (EOFBF) Healthcare & Pipeline Overview

CEOUlrich Tombuelt
Employees72,243
HeadquartersSydney, AU
IPO Year2021

Ecofibre Limited operates in the hemp industry, focusing on CBD products, hemp-based foods, and textiles across the US and Australia. With a negative profit margin and a high beta, the company navigates a complex regulatory environment while competing with established players in the specialty drug and consumer goods markets.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 18, 2026

What Is the Investment Thesis for EOFBF?

AI-written as of Mar 18, 2026 — figures and tone reflect the data available then, not today's score.

Investing in Ecofibre Limited presents a high-risk, high-reward scenario. The company's negative profit margin of -158.5% indicates significant challenges in achieving profitability. Growth catalysts include expansion of product lines within the Ananda Health segment and increased market penetration in the US and Australian markets. The company's high beta of 2.28 suggests significant volatility relative to the broader market. Successful navigation of regulatory hurdles and achieving economies of scale in production and distribution are critical for long-term value creation. Investors should closely monitor the company's progress in improving its financial performance and establishing a sustainable competitive advantage.

Based on FMP financials and quantitative analysis

EOFBF Key Highlights

AI-written as of Mar 18, 2026 — figures and tone reflect the data available then, not today's score.

Market capitalization of $0.00B indicates the company's small size and potential for growth, but also higher risk.

  • Negative P/E ratio of -0.16 reflects the company's current lack of profitability.
  • Profit margin of -158.5% highlights significant challenges in achieving sustainable profitability.
  • Gross margin of -3.9% indicates that the cost of goods sold exceeds revenue, requiring substantial improvements in operational efficiency.
  • Beta of 2.28 suggests high volatility compared to the overall market, potentially offering higher returns but also greater risk.

Who Are EOFBF's Competitors?

EOFBF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
CNTMF Fluent Corp. $0.02 +4.65% $10.5M
CWBHF Charlotte's Web Holdings, Inc. $0.33 -3.93% $88.4M 519-signal
MKKGY Merck KGaA $30.59 +0.33% $66.5B 499-signal
TAK Takeda Pharmaceutical Company Limited $18.11 -0.55% $57.6B 635-pillar
TEVA Teva Pharmaceutical Industries Limited $36.65 +0.84% $42.7B 605-pillar
HLN Haleon plc $9.22 -0.11% $40.6B 775-pillar
SDZNY Sandoz Group AG $81.08 -2.68% $35.1B 519-signal
ZTS Zoetis Inc. $72.89 -0.57% $30.6B 855-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are EOFBF's Key Strengths?

Vertically integrated operations.

  • Proprietary genetics in hemp breeding.
  • Established brands in the CBD and hemp food markets.
  • Operations in both the United States and Australia.

What Are EOFBF's Weaknesses?

Negative profit margin.

  • High beta indicating significant volatility.
  • Limited brand recognition compared to larger competitors.
  • Reliance on evolving regulations.

What Could Drive EOFBF Stock Higher?

EOFBF catalyst: Potential regulatory changes in the US and Australia regarding hemp-derived products could create new market opportunities.

  • Expansion of distribution channels and retail partnerships to increase product availability.
  • Development and launch of new CBD products targeting specific health conditions.

What Are the Key Risks for EOFBF?

Financial-distress signal — its Altman Z-Score of -3.48 sits in the distress zone (elevated bankruptcy risk).

  • Negative return on equity (-77.4%) — the business is not currently generating profit on shareholder capital.
  • Negative profit margin and challenges in achieving profitability.
  • High beta indicating significant volatility.
  • Intense competition from other hemp companies.
  • Evolving and uncertain regulatory environment.
  • Fluctuations in commodity prices for hemp.

What Are the Growth Opportunities for EOFBF?

  • Expansion of Ananda Health Product Line: The market for CBD products is projected to reach $16 billion by 2026. Ecofibre can capitalize on this growth by expanding its Ananda Health product line to include new formulations, delivery methods, and targeted health solutions. This includes developing products for specific conditions such as anxiety, sleep disorders, and pain management. Success hinges on effective marketing, product innovation, and compliance with evolving regulations.
  • Increased Market Penetration in the United States: The US market represents a significant opportunity for Ecofibre. By strengthening its distribution network, enhancing its marketing efforts, and building brand awareness, the company can increase its market share in key states. This includes targeting specific demographic groups and leveraging e-commerce platforms to reach a wider audience. Success depends on effective execution of its sales and marketing strategies.
  • Development of Hemp-Based Textile Products: The market for sustainable textiles is growing rapidly, driven by increasing consumer awareness of environmental issues. Ecofibre can leverage its Hemp Black segment to develop innovative hemp-based textile products for various applications, including apparel, home furnishings, and industrial materials. This includes partnering with fashion brands and manufacturers to promote the use of hemp fabrics. The timeline for significant revenue generation is estimated at 2-3 years.
  • Strategic Partnerships and Acquisitions: Ecofibre can accelerate its growth by forming strategic partnerships with other companies in the hemp industry or acquiring complementary businesses. This includes partnering with retailers, distributors, and technology providers to expand its reach and enhance its capabilities. Potential acquisition targets include companies with established brands, proprietary technologies, or strong distribution networks. The timeline for realizing the benefits of such partnerships or acquisitions is estimated at 1-2 years.
  • Expansion into International Markets: While Ecofibre currently operates in the United States and Australia, there are opportunities to expand into other international markets with favorable regulatory environments for hemp-derived products. This includes countries in Europe, Asia, and Latin America. Market entry strategies may include establishing local partnerships, setting up distribution networks, or acquiring existing businesses. The timeline for successful international expansion is estimated at 2-3 years.

What Are EOFBF's Competitive Advantages?

  • Vertically integrated operations provide control over quality and costs.
  • Proprietary genetics in hemp breeding.
  • Established brands in the CBD and hemp food markets.

What Does EOFBF Do?

Ecofibre Limited, established in 2009 and based in Sydney, Australia, is a vertically integrated company focused on the hemp industry. The company breeds, grows, manufactures, markets, and sells a range of hemp-derived products across its three primary segments: Ananda Health, Ananda Food, and Hemp Black. Ananda Health focuses on CBD products for human and pet consumption, including oils, capsules, and topical creams, targeting the growing market for natural health and wellness solutions. Ananda Food develops and markets hemp-related food products, such as hemp seeds, protein powders, and snacks, catering to health-conscious consumers seeking plant-based alternatives. Hemp Black is dedicated to the development and commercialization of textile and hemp-based products, including sustainable fabrics and industrial materials. Ecofibre's operations span the United States and Australia, reflecting its strategy to capitalize on the evolving regulatory landscape and growing consumer demand for hemp-derived products. The company faces challenges related to profitability, competition, and regulatory uncertainty in the rapidly evolving hemp industry.

What Products and Services Does EOFBF Offer?

  • Breeds and cultivates hemp plants.
  • Manufactures CBD products for human and pet consumption.
  • Develops and markets hemp-related food products.
  • Creates textile and hemp-based products.
  • Markets and sells its products in the United States and Australia.
  • Operates through Ananda Health, Ananda Food, and Hemp Black segments.

How Does EOFBF Make Money?

  • Vertical integration: Controls the entire value chain from breeding to sales.
  • Direct-to-consumer sales: Utilizes online channels to reach customers directly.
  • Wholesale distribution: Partners with retailers to distribute products through physical stores.

What Industry Does EOFBF Operate In?

Ecofibre Limited operates within the rapidly evolving hemp industry, which is experiencing significant growth due to increasing legalization and consumer acceptance of hemp-derived products. The market is highly competitive, with numerous players offering similar products. Key trends include the increasing demand for CBD products for health and wellness, the growing popularity of plant-based foods, and the rising interest in sustainable textiles. Ecofibre competes with companies like AHFGIF, CNTMF, CWBHF, ELXMF, and EVRRF, which are also focused on various segments of the hemp market. The industry is subject to evolving regulations, which can significantly impact the company's operations and growth prospects.

Who Are EOFBF's Key Customers?

  • Health-conscious consumers seeking natural health and wellness solutions.
  • Pet owners looking for CBD products for their pets.
  • Consumers interested in plant-based food alternatives.
  • Manufacturers and brands seeking sustainable textile materials.
Model self-rating on this text: 79% (not a measure of the evidence) Updated: Mar 18, 2026

Research confidence

Low 15/100

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • Scoring coverage unknown
  • Price 5 days old
  • Latest filing 619 days ago
  • No analyst coverage
  • Reported in AUD, converted to USD

MoonshotScore History

Recorded daily since 2026-08-23 · 4 snapshots

2026-08-23 40
2026-08-24 40
2026-08-25 40
2026-08-26 40

What changed?

The score has stayed at 40.

Over the same 3 days the stock moved +0.0%.

Company Profile

Ecofibre Limited operates in the Manufacturing - Textiles industry within the Industrials sector. It is headquartered in Sydney, AU. The company is led by CEO Ulrich Tombuelt. EOFBF has traded publicly since 2021.

Ecofibre Limited Financial Trajectory

Ecofibre Limited (EOFBF) reported $8.9M in revenue for Q2 FY2025, a decline of 18.7% compared to the prior quarter. The company recorded a net loss of $12.7M, with diluted EPS of $-0.03.

ROE -77%

Key Financial Metrics

Return on equity for Ecofibre Limited stands at -77.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -62.2%, showing how much profit it generates from its asset base. A current ratio of 1.80 indicates the company holds enough short-term assets to cover its near-term obligations.

F-Score 4/9

Financial Health

Ecofibre Limited's Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -3.48 places it in the distress zone, a signal of elevated financial risk.

EOFBF Financials

Fundamental Snapshot

Revenue Growth (FY)
-13.9%
Net Income Growth (FY)
-11.1%
Free Cash Flow Growth (FY)
-99.9%
Return on Equity (TTM)
-77.4%
Current Ratio
1.8

Based on FMP financials and quantitative analysis · FY 2024

Bull Case vs Bear Case

Bull Case

  • Vertically integrated operations.
  • Proprietary genetics in hemp breeding.
  • Established brands in the CBD and hemp food markets.
  • Operations in both the United States and Australia.

Bear Case

  • Negative profit margin.
  • High beta indicating significant volatility.
  • Limited brand recognition compared to larger competitors.
  • Reliance on evolving regulations.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q2 FY2025 $9M -$13M -$0.03
Q4 FY2024 $11M $885,222.24 $0.0024

Q2 FY2025 · filed 31 Dec 2024 · Financial Modeling Prep

Based on FMP financials and quantitative analysis · Converted to USD from AUD at today's rate

EOFBF Latest News

No recent news available for EOFBF.

Leadership: Ulrich Tombuelt

CEO

However, as CEO, he is responsible for the overall strategic direction and operational performance of Ecofibre Limited. His role involves overseeing the company's various segments, including Ananda Health, Ananda Food, and Hemp Black, and ensuring the effective execution of its growth strategies. He likely has experience in the healthcare or consumer goods industries, with a focus on marketing, sales, and product development.

Track Record: Due to the limited information available, Ulrich Tombuelt's specific achievements and strategic decisions at Ecofibre Limited cannot be detailed. However, as CEO, he is likely responsible for guiding the company through the evolving regulatory landscape and driving its efforts to achieve profitability and sustainable growth. His performance is likely evaluated based on the company's financial results, market share, and product innovation.

EOFBF OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that Ecofibre Limited may not meet the minimum financial or regulatory requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, be undergoing restructuring, or have other factors that prevent them from listing on a higher tier. Investing in companies on the OTC Other tier carries significant risks due to the lack of transparency and regulatory oversight compared to exchanges like the NYSE or NASDAQ. This tier is generally associated with higher volatility and lower liquidity.

  • OTC Tier: OTC Other
Liquidity: Liquidity on the OTC market for EOFBF is likely to be limited, potentially resulting in wider bid-ask spreads and difficulty in executing large trades without significantly impacting the price. The trading volume may be low, which can increase the risk of price volatility and make it challenging to buy or sell shares quickly. Investors should be prepared for potential delays in order execution and the possibility of unfavorable pricing.
OTC Risk Factors:
  • Limited financial disclosure increases the risk of investing in EOFBF.
  • Low trading volume can lead to price volatility.
  • Wider bid-ask spreads can increase transaction costs.
  • OTC Other tier indicates a higher level of risk compared to listed exchanges.
  • Potential for fraud or manipulation is higher on the OTC market.
Due Diligence Checklist:
  • Verify the company's financial statements and disclosures.
  • Research the company's management team and their track record.
  • Assess the company's business model and competitive landscape.
  • Understand the regulatory environment for the company's products.
  • Evaluate the company's liquidity and trading volume.
  • Consult with a financial advisor before investing.
  • Confirm the legitimacy of the company's operations and assets.
Legitimacy Signals:
  • The company has been in operation since 2009.
  • Ecofibre has operations in both the United States and Australia.
  • The company has a diversified product portfolio across health, food, and textile segments.

EOFBF Healthcare Stock FAQ

What happened to Ecofibre Limited (EOFBF) stock?

Ecofibre Limited (EOFBF) no longer trades on public markets. The figures below are historical and are not a current quote.

Can I still buy EOFBF shares?

No. EOFBF stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for EOFBF elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before EOFBF stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Ecofibre Limited. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

What does Ecofibre Limited do?

Ecofibre Limited is a vertically integrated company that cultivates, manufactures, and sells hemp-derived products across three segments: Ananda Health, Ananda Food, and Hemp Black. Ananda Health focuses on CBD products for human and pet consumption, including oils, capsules, and topical creams. Ananda Food develops and markets hemp-related food products, such as hemp seeds and protein powders.

What are the main risks for EOFBF?

The main risks for Ecofibre Limited include its negative profit margin and challenges in achieving profitability, as evidenced by its -158.5% profit margin.

How does Ecofibre Limited navigate regulatory approval processes?

Identify Ecofibre Limited's expansion into new therapeutic areas, geographic markets, or healthcare segments.

What are the key growth opportunities for EOFBF in healthcare?

Ecofibre Limited has several key growth opportunities within the healthcare sector, primarily through its Ananda Health segment. These opportunities include expanding its product line to target specific health conditions such as anxiety, sleep disorders, and pain management. The company can also explore new delivery methods for its CBD products, such as transdermal patches or inhalers.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Limited financial data available for in-depth analysis.
  • OTC market investments carry higher risks.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover